Tissue processing systems market

According to the report, the global tissue processing systems market was valued at US$ 318.5 Mn in 2019 and is projected to expand at a CAGR of ~5% from 2020 to 2030. Tissue processing involves steps needed to take animal or human tissue from fixation to a state that an appropriate histological wax is thoroughly penetrated and can be embedded on the microtome ready for section cutting. Tissue processing is a method to remove water from cells and replace it with a medium that solidifies to cut thin sections on a microtome. Once tissue is properly fixed, it goes through a process, which involves steps such as dehydration, clearing, and infiltration. Tissue processing can be accomplished manually (hand processing); however, it is more practical and much more effective to use an automatic tissue processing unit when several specimens need to be dealt with. These instruments have been available since the 1940s and have slowly improved to be safer in operation, manage greater quantities of specimens, process faster, and achieve higher quality performance.

North America dominated the global tissue processing systems market in 2019. The trend is anticipated to continue during the forecast period. Strategies adopted by key players such as product approval & launch and mergers & acquisitions, well-established healthcare infrastructure, and early adoption of advanced technologies drive the tissue processing systems market in the region. Asia Pacific accounted for a significant share of the global tissue processing systems market in 2019. The market in the region is likely to expand at a moderate CAGR during the forecast period. Government initiatives in developing countries toward modernization of healthcare infrastructure and rise in awareness about advanced tissue processing systems are the key factors projected to propel the tissue processing systems market in Asia Pacific.

Adoption of Advanced Technologies to Drive Tissue Processing Systems Market
Tissue processing techniques have been greatly revolutionized over the past few years. There are a number of advantages to tissue processor automation such as effective fluid circulation, time saving, and temperature adjustment. The other benefits of automated tissue processors include dramatically increased tissue processing with the aid of automated processors, automatic cleaning cycles, and reagent management system. Moreover, it helps minimize human error. This improves the acceptance of technologically advanced tissue processors, which, in turn, increases the demand for tissue processing systems.

Small Volume Tissue Processors to Dominate Tissue Processing Systems Market
In terms of product type, the global market for tissue processing systems has been categorized into small volume tissue processors, medium volume tissue processors, and high volume tissue processors. The small volume tissue processors segment dominated the global market accounting for a major share in 2019. The trend is projected to continue during the forecast period. It is anticipated to be highly attractive segment from 2020 to 2030. Due to the small amount of reagent required for processing, small volume tissue processors offer excellent balance between durability and reagent saving. In the tissue processing sector, planned introduction and acceptance of small volume tissue processors to meet unmet medical needs is expected to propel the segment during the forecast period.

Bench-top Tissue Processing Units to Drive Tissue Processing Systems Market
Based on modality, the global tissue processing systems market has been bifurcated into bench-top tissue processing unit and portable tissue processing unit. The bench-top tissue processing unit segment dominated the market, accounting for a major share of the market in 2019. The trend is projected to continue during the forecast period. It is anticipated to be a highly attractive segment from 2020 to 2030. The bench-top tissue processing unit provides large collections with high-speed processing, and has an established track record of high efficiency, intuitive feature that decreases training time, and greater productivity. These factors are expected to drive the segment.

Vacuum Tissue Processors to Witness High Demand
In terms of technology, the global market for tissue processing systems has been classified into microwave tissue processors and vacuum tissue processors. The vacuum tissue processors segment dominated the market, accounting for a key share of the market in 2019. The trend is projected to continue during the forecast period. It is anticipated to be a highly attractive segment from 2020 to 2030.

Research Laboratories to be Key End Users
Based on end user, the global tissue processing systems market has been divided into hospitals, pharmaceutical companies, research laboratories, and others. The research laboratories segment is driven by increase in the number of research activities, which help innovate new drug products for life-threatening diseases.

North America to Dominate Tissue Processing Systems Market
In terms of region, the global tissue processing systems market has been segmented into North America, Europe, Asia Pacific, and Rest of the World. North America dominated the global tissue processing systems market in 2019, followed by Europe. North America accounted for a major share of the global tissue processing systems market in 2019. Presence of key players, adoption of advanced tissue processing systems, and focus on research & development are the key factors anticipated to drive the tissue processing systems market in the region. The tissue processing systems market in Asia Pacific is likely to expand at a moderate CAGR during the forecast period. Strategies adopted by key players to address the unmet needs of cancer treatment in developing regions are likely to boost the market in the region.

Competition Landscape
The global tissue processing systems market is fragmented in terms of number of players. Key players in the global tissue processing systems market include Thermo Fisher Scientific, JOKOH, Danaher (Leica Biosystems Nussloch GmbH), MEDITE Medical GmbH, MILESTONE Srl, Sakura Finetek USA, Inc., SLEE medical GmbH, Bio-Optica Milano Spa, Histo-Line Laboratories, and Intelsint Srl. – Transparency Market Research